3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
24
Phase 2
9
Phase 4
2
Phase 3
2
Phase 1/2
2
Phase 1
2
Phase EARLY_PHASE1
1
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
1
Other
1
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
1
Sexual Dysfunction, Physiological
1
Lung Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Dexamethasone
56
Metformin
50
Cyclophosphamide
47
Saline Solution
39
Cytarabine
37
Cisplatin
36
Zoledronic Acid
34
Letrozole
34
Carboplatin
33
Sodium Chloride
32
Bupivacaine
31
Docetaxel
30
Bevacizumab
30
Vincristine
29
Methotrexate
29
Fluorouracil
28
Propofol
27
Capecitabine
27
Fentanyl
26
Doxorubicin
26
Rituximab
25
Drug Therapy
25
Dexmedetomidine
25
Prednisone
23
Paclitaxel
23
Oxaliplatin
21
Morphine
21
Gemcitabine
21
Radiotherapy
19
Prednisolone
19
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 4
×
Interventional
×
Quality of Life
×
Clear all
NCT06646471
2026-04-29
PROMETHEE
Groupe Francais De Pneumo-Cancerologie
Phase 4
Recruiting
500 enrolled
NCT06031493
2024-02-28
PROVIDENCE
Hospital Clinic of Barcelona
Phase 4
Unknown
122 enrolled